What now for compulsory licences?
Today India has granted its first compulsory licence over a drug. But what of other countries that have used the IP system to make it easier for patients to access medicines?
Six years ago the government of Thailand took a decision that sent research pharmaceutical companies into a panic: it issued a compulsory licence for Merck’s antiretroviral drug efavirenz.
The product is marketed by Bristol-Myers Squibb in the US...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.